Event Type
Disclosure
Voluntary
Variant
8-K
Other Events . On October 20, 2025, Replimune Group, Inc. (the “Company”) issued a news release announcing that the U.S. Food and Drug Administration (the “FDA”
Financial Statements and Exhibits . Exhibit No. Description 99.1 News Release dated October 20, 2025 104 Cover page interactive data file (formatted as Inline X